title: Two cell cycle blocks caused by iron chelation of neuroblastoma cells: separating cell cycle events associated with each block.
abstract: Studies have presented evidence that besides the well described S phase block, treatment of cancer cell lines with the iron chelator deferrioxamine (DFO) also results in an earlier block in G1 phase. In this article, measurements of cell cycle regulatory proteins define this block at a very specific point in G1. DFO treatment results in markedly decreased cyclin A protein levels. Cyclin E levels that accumulate in early to mid-G1 are increased in cells treated with DFO as compared to the resting cells. The DFO S phase block is shown after cells are arrested at G1/S by (aphidicolin) then released into DFO. The same S phase block occurs with DFO treatment of a neuroblastoma cell line relatively resistant to the G1 DFO block. These experiments clearly differentiate the S phase DFO block from the earlier block pinpointed to a point in mid-G1, before G1/S when cyclin E protein increases but before increased cyclin A synthesis. Apoptosis was observed in cells inhibited by DFO at both cell cycle arrest points.
authors.affiliation: Division of Hematology, Hematologic Malignancies and Stem Cell Transplantation, University of Colorado School of Medicine, 12700 E. 19th Avenue, Room 9122RC 2, MS B170, Aurora, 80045, Colorado.
authors.forename: Gamini
authors.initials: G
authors.lastname: Siriwardana
authors.affiliation: Division of Hematology, Hematologic Malignancies and Stem Cell Transplantation, University of Colorado School of Medicine, 12700 E. 19th Avenue, Room 9122RC 2, MS B170, Aurora, 80045, Colorado.
authors.forename: Paul A
authors.initials: PA
authors.lastname: Seligman
keywords: Cell cycle; iron chelation; neuroblastoma
references.citation: Cancer Res. 1987 Apr 1;47(7):1749-50
references.pmid: 3815370
references.citation: Curr Med Chem. 2012;19(17):2689-702
references.pmid: 22455580
references.citation: Biochim Biophys Acta. 2002 Oct 2;1603(1):31-46
references.pmid: 12242109
references.citation: Cancer Res. 1993 Sep 1;53(17):3968-75
references.pmid: 8358725
references.citation: Br J Pharmacol. 2013 Mar;168(6):1316-28
references.pmid: 23126308
references.citation: J Natl Cancer Inst. 2008 Jul 16;100(14):996-1002
references.pmid: 18612130
references.citation: Am J Hematol. 1992 Dec;41(4):232-40
references.pmid: 1337663
references.citation: Am J Clin Oncol. 1992 Aug;15(4):319-22
references.pmid: 1514528
references.citation: Am J Pediatr Hematol Oncol. 1992 May;14(2):97-102
references.pmid: 1382390
references.citation: Mol Endocrinol. 2006 Sep;20(9):2010-9
references.pmid: 16613992
references.citation: Anticancer Res. 1992 Mar-Apr;12(2):481-3
references.pmid: 1580565
references.citation: Biochem Biophys Res Commun. 2013 May 3;434(2):241-4
references.pmid: 23542465
references.citation: Genes Dev. 1992 Oct;6(10):1874-85
references.pmid: 1398067
references.citation: Clin Cancer Res. 2003 Jan;9(1):402-14
references.pmid: 12538494
references.citation: Blood. 2007 Jul 15;110(2):752-61
references.pmid: 17429006
references.citation: Biochem Pharmacol. 1982 Oct 1;31(19):3107-13
references.pmid: 6216891
references.citation: Korean J Hematol. 2012 Sep;47(3):194-201
references.pmid: 23071474
references.citation: J Lab Clin Med. 1988 Oct;112(4):433-6
references.pmid: 2459279
references.citation: J Biol Chem. 2004 Jan 2;279(1):223-30
references.pmid: 14573610
references.citation: Nature. 2004 Nov 18;432(7015):316-23
references.pmid: 15549093
references.citation: Curr Opin Drug Discov Devel. 2001 Sep;4(5):623-34
references.pmid: 12825457
references.citation: Mol Cell Biol. 2003 Dec;23(23):8586-600
references.pmid: 14612403
references.citation: Proc Natl Acad Sci U S A. 1970 Aug;66(4):1244-51
references.pmid: 4920092
references.citation: Biochemistry. 1991 Sep 3;30(35):8590-7
references.pmid: 1909569
references.citation: Science. 1996 Mar 29;271(5257):1861-4
references.pmid: 8596954
references.citation: Semin Oncol. 1992 Jun;19(3 Suppl 9):1-10
references.pmid: 1641648
references.citation: J Biol Chem. 2011 Dec 2;286(48):41499-41509
references.pmid: 21931161
references.citation: Cancer Res. 1992 Sep 1;52(17):4591-9
references.pmid: 1511427
references.citation: Hematol Oncol. 1986 Jul-Sep;4(3):195-204
references.pmid: 3095210
references.citation: Blood. 2007 May 1;109(9):4045-54
references.pmid: 17197429
references.citation: Genes Dev. 1998 Dec 15;12(24):3882-8
references.pmid: 9869641
references.citation: Nucleic Acids Res. 1981 Sep 25;9(18):4709-19
references.pmid: 6795595
references.citation: Lancet. 1977 May 7;1(8019):977-9
references.pmid: 67469
references.citation: Cytometry. 1992;13(2):137-43
references.pmid: 1372208
references.citation: PLoS One. 2013 Aug 26;8(8):e74075
references.pmid: 23991213
references.citation: Cell. 1993 Jun 18;73(6):1059-65
references.pmid: 8513492
references.citation: Mol Pharmacol. 2013 Jan;83(1):179-90
references.pmid: 23074173
references.citation: J Biol Chem. 2002 Jul 12;277(28):25568-75
references.pmid: 11980894
references.citation: J Biol Chem. 1984 Oct 10;259(19):11695-700
references.pmid: 6090444
references.citation: Biochem Biophys Res Commun. 1977 Apr 11;75(3):556-62
references.pmid: 301024
references.citation: Blood. 1984 Sep;64(3):748-53
references.pmid: 6380622
references.citation: Mol Cancer. 2007 Aug 30;6:55
references.pmid: 17760959
references.citation: Mol Cell. 2011 Dec 9;44(5):683-4
references.pmid: 22152471
references.citation: J Natl Cancer Inst. 1991 Nov 6;83(21):1582-4
references.pmid: 1960756